You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
海利生物(603718.SH)2021年度淨利潤5385.67萬元 同比增長503.33%
格隆匯 04-28 21:54

格隆匯4月28日丨海利生物(603718.SH)發佈2021年年度報吿,實現營業收入3.47億元,同比增長34.02%;歸屬於上市公司股東的淨利潤5385.67萬元,同比增長503.33%;歸屬於上市公司股東的扣除非經常性損益的淨利潤2271.88萬元,上年同期為虧損1491.53萬元;基本每股收益0.08元。

鑑於公司目前處於快速發展及新業務拓展階段,公司日常經營、業務拓展、對外投資及新項目投資建設均需要大量資金投入,綜合考慮公司未來資金支出計劃、目前經營及資金狀況、股東中長期回報,公司擬定2021年度利潤分配預案:2021年度不進行現金分紅、送股、資本公積金轉增股本。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account